rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 

Glivec

Rediff.com  »  News  »   Glivec

  News for Glivec

  • Business

'Novartis case: SC ruling wise and balanced'

The Supreme Court recently rejected the plea of Novartis AG for patent protection of its anti-cancer drug Glivec.The Supreme Court  judgement (pages 22 -26) quite extensively quoted from Sudip......

'Judgment will ensure no ever-greening of patents'

Though the legal battle over Glivec’s patentability may be over for now, Y K Sapru, the man spearheading the fight against Swiss multinational Novartis, isn’t resting. Sapru, founder......

'Novartis ruling won't affect pharma industry'

Novartis's famed cancer drug, Glivec, will not get patent protection in India. The apex body on patent and trademark disputes, the Intellectual Property Appellate Board, has recently ruled that the......

'US industry reviewing SC decision on Novartis'

The US industry said on Wednesday it is reviewing the order of the Supreme Court early this week that denied patent on Glivec, a cancer medication produced by Swiss drug maker Novartis, as......

The man behind Glivec hails verdict against Novartis

Even though Novartis and other multinational corporations are upset with the Indian Supreme Court’s decision to reject Novartis’ patent claim on Glivec, the key man behind the popular......
  Web results for Glivec
India, Brazil cross swords with U.S. at WTO

Comment · print · T T T+· T- TOPICS Moratorium on Intellectual Property Complaints Switzerland and the U.S. have begun a campaign... ...

http://www.thehindu.com/business/india-brazil-cross-swords-with-us-at-wto/article7347311.ece?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS_Syndication
Novartis' phase 3b ENEST1st study shows benefit of first-line Tasigna in newly-diagnosed patients with CML

Novartis, a global healthcare leader, announced results from the phase 3b ENEST1st study in over 1,000 patients with newly-diagnosed, BCR-ABL... ...

http://www.pharmabiz.com/NewsDetails.aspx?aid=88891&sid=2
India to resist push for patent legislation

NEW DELHI: India will resist a push by Japan and South Korea for stringent patent legislation at the eighth round of negotiations for Regional... ...

http://economictimes.indiatimes.com/news/economy/policy/india-to-resist-japan-and-south-koreas-push-for-patent-legislation-at-rcep/articleshow/47636517.cms
India's patent law may face legal hurdle at WTO

The majority of countries at WTO want a permanent moratorium in place, a South American trade official said. Photo: AFP Geneva: India's amended... ...

http://www.livemint.com/Politics/HyWtICLQJL3LDGGAEoC3tM/Indias-patent-law-may-face-legal-hurdle-at-WTO.html
Novartis places big, broad bet on cancer immunotherapy

Novartis is well placed in the hot field of cancer immunotherapy, despite being behind rivals in developing immune system-boosting drugs known as... ...

http://in.reuters.com/article/2015/06/08/us-novartis-cancer-idINKBN0OO21320150608?feedType=RSS&feedName=health

Related Tags


  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Top Coverage News


Coming to India and making

Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z